Cargando…
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
BACKGROUND: DNA methylation was suggested as the promising biomarker for lung cancer diagnosis. However, it is a great challenge to search for the optimal combination of methylation biomarkers to obtain maximum diagnostic performance. RESULTS: In this study, we developed a panel of DNA methylation b...
Autores principales: | Guo, Shicheng, Yan, Fengyang, Xu, Jibin, Bao, Yang, Zhu, Ji, Wang, Xiaotian, Wu, Junjie, Li, Yi, Pu, Weilin, Liu, Yan, Jiang, Zhengwen, Ma, Yanyun, Chen, Xiaofeng, Xiong, Momiao, Jin, Li, Wang, Jiucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318209/ https://www.ncbi.nlm.nih.gov/pubmed/25657825 http://dx.doi.org/10.1186/s13148-014-0035-3 |
Ejemplares similares
-
Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer
por: Guo, Shicheng, et al.
Publicado: (2014) -
Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016) -
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017) -
Bagging Nearest-Neighbor Prediction independence Test: an efficient method for nonlinear dependence of two continuous variables
por: Wang, Yi, et al.
Publicado: (2017) -
Genome-Wide DNA Methylation Profiles Reveal Common Epigenetic Patterns of Interferon-Related Genes in Multiple Autoimmune Diseases
por: Chen, Sidi, et al.
Publicado: (2019)